Vialev combination continuous subcutaneous injection, manufactured by AbbVie, contains foslevodopa/foscarbidopa hydrate. This combination medication is used for the continuous subcutaneous treatment of motor fluctuations in advanced Parkinson’s disease. It is an injectable drug of 10mL 1 bottle with YJ code 1169500A1023.
Vialev combination continuous subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →